Susquehanna Portfolio Strategies, LLC Ionis Pharmaceuticals Inc Transaction History
Susquehanna Portfolio Strategies, LLC
- $2.43 Trillion
- Q2 2024
A detailed history of Susquehanna Portfolio Strategies, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Susquehanna Portfolio Strategies, LLC holds 43,028 shares of IONS stock, worth $1.68 Million. This represents 0.08% of its overall portfolio holdings.
Number of Shares
43,028
Previous 130,986
67.15%
Holding current value
$1.68 Million
Previous $5.68 Billion
63.88%
% of portfolio
0.08%
Previous 0.13%
Shares
3 transactions
Others Institutions Holding IONS
# of Institutions
394Shares Held
125MCall Options Held
2.25MPut Options Held
510K-
Vanguard Group Inc Valley Forge, PA13.8MShares$541 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD12.6MShares$494 Million0.38% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$403 Million0.01% of portfolio
-
Bellevue Group Ag Kuesnacht, V88.26MShares$323 Million6.59% of portfolio
-
Wellington Management Group LLP Boston, MA6.57MShares$257 Million0.06% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.55B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...